1. Home
  2. FRLA vs NTRB Comparison

FRLA vs NTRB Comparison

Compare FRLA & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FRLA
  • NTRB
  • Stock Information
  • Founded
  • FRLA 2021
  • NTRB 2016
  • Country
  • FRLA United States
  • NTRB United States
  • Employees
  • FRLA N/A
  • NTRB N/A
  • Industry
  • FRLA
  • NTRB Industrial Specialties
  • Sector
  • FRLA
  • NTRB Health Care
  • Exchange
  • FRLA NYSE
  • NTRB Nasdaq
  • Market Cap
  • FRLA 71.4M
  • NTRB 77.9M
  • IPO Year
  • FRLA 2021
  • NTRB N/A
  • Fundamental
  • Price
  • FRLA $11.38
  • NTRB $7.10
  • Analyst Decision
  • FRLA
  • NTRB
  • Analyst Count
  • FRLA 0
  • NTRB 0
  • Target Price
  • FRLA N/A
  • NTRB N/A
  • AVG Volume (30 Days)
  • FRLA 7.3K
  • NTRB 42.2K
  • Earning Date
  • FRLA 01-01-0001
  • NTRB 12-11-2024
  • Dividend Yield
  • FRLA N/A
  • NTRB N/A
  • EPS Growth
  • FRLA N/A
  • NTRB N/A
  • EPS
  • FRLA N/A
  • NTRB N/A
  • Revenue
  • FRLA N/A
  • NTRB $1,803,816.00
  • Revenue This Year
  • FRLA N/A
  • NTRB N/A
  • Revenue Next Year
  • FRLA N/A
  • NTRB N/A
  • P/E Ratio
  • FRLA N/A
  • NTRB N/A
  • Revenue Growth
  • FRLA N/A
  • NTRB N/A
  • 52 Week Low
  • FRLA $10.94
  • NTRB $1.53
  • 52 Week High
  • FRLA $11.87
  • NTRB $9.60
  • Technical
  • Relative Strength Index (RSI)
  • FRLA 52.55
  • NTRB 58.43
  • Support Level
  • FRLA $11.36
  • NTRB $7.05
  • Resistance Level
  • FRLA $11.42
  • NTRB $8.49
  • Average True Range (ATR)
  • FRLA 0.02
  • NTRB 0.62
  • MACD
  • FRLA -0.00
  • NTRB 0.09
  • Stochastic Oscillator
  • FRLA 33.33
  • NTRB 50.18

About FRLA FORTUNE RISE ACQUISITION CORP

Fortune Rise Acquisition Corp is a blank check company.

About NTRB Nutriband Inc.

Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.

Share on Social Networks: